Your browser doesn't support javascript.
loading
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.
Kastritis, Efstathios; Terpos, Evangelos; Symeonidis, Argiris; Labropoulou, Vasiliki; Delimpasi, Sosana; Mancuso, Katia; Zamagni, Elena; Katodritou, Eirini; Rivolti, Elena; Kyrtsonis, Marie-Christine; Roussou, Maria; Fotiou, Despina; Theodorakakou, Foteini; Ntanasis-Stathopoulos, Ioannis; Hatjiharissi, Evdoxia; Kanellias, Nikolaos; Migkou, Magdalini; Cheliotis, Giorgos; Manousou, Kyriaki; Gavriatopoulou, Maria; Dimopoulos, Meletios A.
Afiliação
  • Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Symeonidis A; Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece.
  • Labropoulou V; Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece.
  • Delimpasi S; Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece.
  • Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Zamagni E; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Katodritou E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Rivolti E; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
  • Kyrtsonis MC; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.
  • Roussou M; Department of Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Fotiou D; First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Theodorakakou F; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Hatjiharissi E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Kanellias N; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Migkou M; First Department of Internal Medicine, Division of Hematology, AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece.
  • Cheliotis G; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Manousou K; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Gavriatopoulou M; Health Data Specialists, Dublin, Ireland.
  • Dimopoulos MA; Health Data Specialists, Dublin, Ireland.
Am J Hematol ; 98(9): E226-E229, 2023 09.
Article em En | MEDLINE | ID: mdl-37340832
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article